As the peptide industry continues to mature, the conversations shaping its future extend far beyond science alone. A recent Forbes feature, One Chargeback: Inside the $1 Billion Peptide Payments Machine, examines one of the industry's most critical—but often overlooked—challenges: building reliable financial infrastructure for a rapidly growing market.
The article explores how payment stability, compliance, and purpose-built financial solutions are becoming essential for peptide businesses navigating an increasingly complex regulatory environment. As the industry continues to evolve, strengthening these foundational systems will play a key role in supporting responsible growth, protecting providers, and fostering greater confidence across the marketplace.
Read the Full Article
Read One Chargeback: Inside the $1 Billion Peptide Payments Machine on Forbes: